What to do if the apex of the lung becomes inflamed

The lungs are very important to people's bodies. This organ is directly related to whether the patient's breathing is smooth. If there are inflammatory changes in the apex of the lung, the patient's breathing will definitely become less smooth. If the patient is in a more serious condition, it will also cause symptoms of long-term coughing. If the cough is severe, it will definitely affect the patient's sleep quality. Therefore, you must pay special attention to it. Once you find that your lungs are inflamed, you must choose the corresponding treatment method according to your own situation. This is the right medicine for the disease. Among them, anti-infection treatment measures are absolutely an indispensable link. This is a situation that determines the patient's prognosis.

Western medicine treatment

1. Anti-infection treatment is the most important part of pneumonia treatment. Treatment of bacterial pneumonia includes empirical therapy and treatment directed at the pathogen. The former mainly selects antimicrobial drugs that may cover pathogens based on the epidemiological data of pneumonia pathogens in the region or unit; the latter selects antimicrobial drugs that are sensitive in in vitro tests based on the culture and drug sensitivity test results of respiratory or lung tissue specimens. In addition, the selection of antimicrobial drugs and routes of administration should be based on the patient's age, underlying diseases, aspiration, whether the patient is in a general ward or intensive care unit, length of hospitalization, and severity of pneumonia.

2. For young and middle-aged patients with community-acquired pneumonia without underlying diseases, penicillins, first-generation cephalosporins, etc. are commonly used. Due to the high resistance rate of Streptococcus pneumoniae to macrolide antibiotics in my country, macrolide antibiotics are not used alone to treat pneumonia caused by this bacteria. Fluoroquinolones (moxifloxacin, gemifloxacin and levofloxacin) that are specifically effective for respiratory infections can be used for resistant Streptococcus pneumoniae.

3. For the elderly, patients with underlying diseases or community-acquired pneumonia who require hospitalization, fluoroquinolones, second- and third-generation cephalosporins, β-lactam/β-lactamase inhibitors, or ertapenem are commonly used, and can be combined with macrolides.

4. Second- and third-generation cephalosporins, β-lactam β-lactamase inhibitors, fluoroquinolones or carbapenems are commonly used for hospital-acquired pneumonia.

5. The treatment of severe pneumonia should first select broad-spectrum strong antibiotics, and should be used in sufficient doses and in combination. Because the initial empirical treatment is insufficient or unreasonable, or the antimicrobial drugs are adjusted according to the etiological results, the mortality rate is significantly higher than that of those with correct initial treatment. Severe community-acquired pneumonia is often treated with β-lactams combined with macrolides or fluoroquinolones; fluoroquinolones and aztreonam are used for those who are allergic to penicillin. Hospital-acquired pneumonia can be treated with fluoroquinolones or aminoglycosides combined with any of the anti-Pseudomonas β-lactams, broad-spectrum penicillins/β-lactamase inhibitors, or carbapenems, and, if necessary, with vancomycin, teicoplanin, or linezolid.